11. Pharmacovigilance: A Complete Guide for Pharmacy Students

PHARMACOVIGILANCE: A TEACHER’S COMPREHENSIVE GUIDE

Welcome, future pharmacists and healthcare professionals!

As a pharmacy educator with years of experience teaching hospital and clinical pharmacy, I have always emphasized that pharmacovigilance is the science of monitoring the safety of medicines. The term is derived from the Greek word “pharmacon” meaning drug and the Latin word “vigilare” meaning to keep watch. It focuses on the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs).

In this comprehensive guide, I will take you through the fundamentals of pharmacovigilance. We will explore its definition, aims, scope, history, development in India, and the significance of pharmacovigilance in modern healthcare. By the end of this article, you will have a thorough understanding of how pharmacovigilance contributes to patient safety and public health. Let us begin.

WHAT IS PHARMACOVIGILANCE?

According to the World Health Organization (WHO), pharmacovigilance is defined as “the science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions to medicines” (particularly long-term and short-term adverse effects). The European Commission (EU) defines pharmacovigilance as “the science and process to monitor the safety of medicinal drugs and take actions for increasing the benefits and reducing risks of medicines”.

Pharmacovigilance is a systematic activity in the medical field that has significant social and economic ramifications. It is meant to evaluate medication risk/benefit ratios while enhancing patient safety and quality of life. The discipline ensures that medicines are used safely and effectively, minimizing the risks associated with drug therapy.

AIMS OF PHARMACOVIGILANCE

The aims of pharmacovigilance are comprehensive and patient-centered:

• To improve patient care and safety: Associated with the use of medicines as well as all medical and paramedical interventions.
• To improve public health and safety: Associated with the use of medicines at the population level.
• To identify complications: Associated with the use of medicines and conveying them in an appropriate manner.
• To evaluate advantage, efficacy and risk: Of medicines as well as promoting safe, rational and more effective (including cost-effective) use of these drugs.
• To encourage education, understanding and clinical training: In pharmacovigilance along with its effective communication to healthcare workers and the public.

SCOPE OF PHARMACOVIGILANCE

Pharmacovigilance plays a critical role in providing safety from toxic effects of therapeutic drugs across several areas:

1. Herbal Medicines

The safety and efficacy of herbal medicines has become a key concern to both the general public and national health authorities. The use of herbal plants in traditional and ancient medicine systems continues to expand rapidly all over the world. Nowadays, people are shifting towards herbal medicinal systems or herbal drugs for the treatment of various diseases. Pharmacovigilance ensures that herbal medicines are monitored for adverse effects, drug interactions, and quality issues.

2. Disease Control Public Health Programs

A major concern in countries having no safety monitoring or regulatory system, or in remote areas having few or no healthcare surveillance or infrastructure, is monitoring the safety of medicines. The primary problem occurs in specific communities where the use of medicines becomes difficult, for example, for the treatment of tropical diseases such as leishmaniasis, malaria, schistosomiasis, tuberculosis, and HIV/AIDS. Pharmacovigilance must be a priority for every country with a public health disease control programme.

3. Ecopharmacovigilance

Adverse drug reactions related to drugs within the ecosystem with all consequences in human beings and other organisms in the environment are included in ecopharmacovigilance. Examples include:

• Patient excretion of drugs or their metabolites through the sewage system.
• Hospital or self-disposal of unused, expired, or unwanted drugs through flushing or trash.
• Direct release of drugs and their byproducts from manufacturing units into the wastewater system.
• Terrestrial deposition from solid waste landfills and sludge application to lands.
• Rapid breakdown of acetylsalicylic acid leading to deposition in lands.
• Clofibric acid (active metabolite of clofibrate) detected in drinking water.
• Fluoroquinolones (fat-soluble and stable drugs) getting absorbed to sludge particles through sewage treatment processes.

4. Blood Banks

In blood banks, pharmacovigilance plays an important role by keeping a record of all donors donating blood, their health safety data, etc. For example, if a person who has suffered from dengue fever in the past donates blood and any type of adverse reaction is observed in the patient receiving the same blood, the pharmacovigilance team keeps a record of the adverse drug reaction that occurred due to the donated blood.

5. Immunisation and Vaccination

Pharmacovigilance plays a crucial role in vaccination. There are certain vaccines that have been given to patients and serious adverse reactions have been observed, or when the dosage form gets changed, any kind of adverse event must be checked from time to time. For example, the polio vaccine was initially given as polio drops, but recently the manufacturers changed the dosage form to injectable. Therefore, after vaccination of polio injections, the site of injection has to be kept on check for any kind of inflammation, thrombosis, or other skin reactions.

6. Dermatology

In order to keep a check on any type of skin reactions or adverse events related to skin diseases, pharmacovigilance plays an important role in the area of dermatology. Skin reactions are among the most common adverse drug reactions, and monitoring them is essential for patient safety.

HISTORY AND DEVELOPMENT OF PHARMACOVIGILANCE

Approximately 170 years ago, pharmacovigilance began, though it was not yet known by that name. Key milestones in its development include:

• 1848: Chloroform death case – first recorded instance of an anaesthetic-related death.
• 1937: Sulfanilamide tragedy – a toxic solvent used in an elixir formulation caused mass poisoning.
• Aspirin: Identified gastrointestinal side effects over time.
• 1961: Thalidomide disaster – the drug caused severe birth defects in thousands of babies, leading to the establishment of modern pharmacovigilance systems.

These tragic events highlighted the need for systematic monitoring of drug safety and led to the development of pharmacovigilance as a formal discipline.

PHARMACOVIGILANCE IN INDIA

The development of pharmacovigilance in India has been a gradual process:

• 1986: ADR monitoring started in India.
• 1997: India joined the WHO monitoring program.
• 2004–2005: The National Pharmacovigilance Program was launched.
• Multiple ADR monitoring centers were established across the country.
• Coordinated by national regulatory bodies such as the Central Drugs Standard Control Organization (CDSCO) and the National Pharmacovigilance Advisory Committee.

These bodies monitor drug safety and collect adverse drug reaction reports from healthcare professionals and consumers.

IMPORTANT ORGANIZATIONS IN PHARMACOVIGILANCE

• Central Drugs Standard Control Organization (CDSCO): The national regulatory authority for pharmaceuticals in India. It oversees drug approval, safety monitoring, and regulatory compliance.
• National Pharmacovigilance Advisory Committee: Provides guidance and recommendations on pharmacovigilance activities in India.
• WHO Collaborating Centre for Pharmacovigilance: Coordinates global pharmacovigilance activities and maintains the VigiBase database of ADR reports.

SIGNIFICANCE OF PHARMACOVIGILANCE

• Drug Surveillance: Continuous monitoring of drug safety after market approval helps identify rare or long-term adverse effects.
• ADR Monitoring: Detect harmful drug reactions that may not have been identified during clinical trials.
• ADR Reporting: Reporting systems help prevent future risks by providing data for regulatory action.
• Post-Marketing Studies: Ensure long-term safety and effectiveness of medicines in real-world settings.

OVERVIEW OF PHARMACOVIGILANCE

Pharmacovigilance is a systematic activity in the medical field that has significant social and economic ramifications. It is meant to evaluate medication risk/benefit ratios while enhancing patient safety and quality of life. The key components of pharmacovigilance include:

• Systematic evaluation of drug safety: Ongoing monitoring of medicines throughout their lifecycle.
• Improves quality of life: By preventing adverse drug reactions and ensuring safe medication use.
• Balances risks and benefits: Helps healthcare professionals and regulators make informed decisions about drug use.

A TEACHER’S PRACTICAL INSIGHTS

Over my years of teaching, I have developed a few key insights about pharmacovigilance that I always share with my students:

• Think about the patient: Pharmacovigilance is ultimately about patient safety. Every ADR report can help prevent harm to future patients.
• Report ADRs: Healthcare professionals have a responsibility to report adverse drug reactions. Do not assume someone else will do it.
• Stay updated: New safety information about drugs is constantly emerging. Stay updated with pharmacovigilance alerts and guidelines.
• Educate patients: Patients should be informed about potential side effects and encouraged to report any unusual symptoms.

FREQUENTLY ASKED QUESTIONS (FAQs)

1. What is pharmacovigilance?

Pharmacovigilance is the science of monitoring the safety of medicines, focusing on detection, assessment, understanding, and prevention of adverse drug reactions.

2. What are the aims of pharmacovigilance?

The aims include improving patient safety, enhancing public health, identifying adverse drug effects, evaluating risk-benefit ratios, and promoting rational drug use.

3. What is the scope of pharmacovigilance?

The scope includes herbal medicines, public health programs, ecopharmacovigilance, blood banks, immunization, and dermatology.

4. What is ecopharmacovigilance?

Ecopharmacovigilance is the study of adverse drug reactions related to drugs within the ecosystem, including their impact on the environment and living organisms.

5. What was the Thalidomide disaster?

The Thalidomide disaster in 1961 involved a drug that caused severe birth defects in thousands of babies, leading to the establishment of modern pharmacovigilance systems.

6. When did pharmacovigilance start in India?

ADR monitoring started in India in 1986. India joined the WHO monitoring program in 1997, and the National Pharmacovigilance Program was launched in 2004–2005.

7. Why is pharmacovigilance important?

Pharmacovigilance is important because it ensures drug safety, detects adverse effects, prevents future risks, and promotes rational use of medicines.

SUMMARY

Pharmacovigilance is the science of monitoring the safety of medicines. It focuses on the detection, assessment, understanding, and prevention of adverse drug reactions. The aims of pharmacovigilance include improving patient safety, enhancing public health, identifying adverse effects, evaluating risk-benefit ratios, and promoting rational drug use.

The scope of pharmacovigilance includes herbal medicines, public health programs, ecopharmacovigilance, blood banks, immunization, and dermatology. Its history includes significant events such as the Thalidomide disaster, which highlighted the need for systematic drug safety monitoring. In India, pharmacovigilance has evolved since 1986, with the establishment of ADR monitoring centers and the National Pharmacovigilance Program.

Pharmacovigilance is essential for ensuring patient safety, preventing adverse drug reactions, and promoting rational use of medicines.

As I always tell my students: “Pharmacovigilance is the guardian of drug safety. It ensures that the medicines we use are not just effective but also safe.”

REFERENCES & FURTHER READING

• World Health Organization (WHO). (2023). Pharmacovigilance Guidelines. Retrieved from WHO Official Website.
• Central Drugs Standard Control Organization (CDSCO). (2023). Pharmacovigilance Program of India. Retrieved from CDSCO Official Website.
• International Pharmaceutical Federation (FIP). (2023). Pharmacovigilance Practice Guidelines. Retrieved from FIP Official Website.
• Uppsala Monitoring Centre (UMC). (2023). VigiBase and Global Pharmacovigilance. Retrieved from UMC Official Website.
• National Pharmacovigilance Advisory Committee (NPAC). (2023). ADR Reporting Guidelines. Retrieved from NPAC Official Website.

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. Always consult qualified healthcare professionals and regulatory authorities for professional and legal matters.